Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
| Autor: | Gregory J. Riely, Cheryl Goss, Scott T. Avecilla, Maria M. Rubinstein, Jodi V. Mones, Gregory P. Dubé |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Thymoma Jehovah s witness lcsh:Medicine Pure red cell aplasia Case Report Case Reports 030204 cardiovascular system & hematology Blood substitute Hemopure 03 medical and health sciences red blood cell alternatives 0302 clinical medicine hemic and lymphatic diseases medicine lcsh:R5-920 business.industry Bovine hemoglobin lcsh:R General Medicine medicine.disease 3. Good health Surgery hemopure pure red cell aplasia 030220 oncology & carcinogenesis hemoglobin‐based oxygen carrier lcsh:Medicine (General) business |
| Zdroj: | Clinical Case Reports Clinical Case Reports, Vol 8, Iss 2, Pp 289-292 (2020) |
| ISSN: | 2050-0904 |
| Popis: | Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure®, Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient. Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure ®, Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text